Antibiotics, corticosteroids beneficial in COPD exacerbations

Antibiotics, corticosteroids beneficial in COPD exacerbations

(HealthDay)—For adults with exacerbation of chronic obstructive pulmonary disease (COPD), antibiotics and systemic corticosteroids are associated with less treatment failure, according to a review published online Feb. 25 in the Annals of Internal Medicine.

Claudia C. Dobler, M.D., Ph.D., from the Mayo Clinic in Rochester, Minnesota, and colleagues assessed the comparative effectiveness and adverse events (AEs) of pharmacologic interventions for adults with COPD exacerbation. Data were included from 68 randomized controlled trials enrolling adults with exacerbation of COPD that compared pharmacologic therapies to placebo, usual care, or other pharmacologic interventions.

The researchers found that independent of severity of exacerbations in outpatients and inpatients, antibiotics given for three to 14 days were associated with increased resolution of exacerbation and less treatment failure at the end of the intervention (odds ratios, 2.03 and 0.54, respectively) compared with placebo or management without antibiotics. Systemic corticosteroids given for nine to 56 days were associated with less treatment failure at the end of the intervention (odds ratio, 0.01) compared with placebo in outpatients and inpatients, but with a higher number of total and endocrine-related AEs. Insufficient evidence was found for other pharmacologic interventions compared with placebo or usual care in inpatients.

"The results of this systematic review support use of and in COPD exacerbations, independent of severity," the authors write.

Explore further

Azithromycin appears to reduce treatment failure in severe, acute COPD exacerbations

More information: Abstract/Full Text (subscription or payment may be required)
Journal information: Annals of Internal Medicine

Copyright © 2020 HealthDay. All rights reserved.

Citation: Antibiotics, corticosteroids beneficial in COPD exacerbations (2020, February 25) retrieved 20 January 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments